2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxa2
|
ENSMUSG00000037025.5 | forkhead box A2 |
Foxa1
|
ENSMUSG00000035451.6 | forkhead box A1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxa2 | mm10_v2_chr2_-_148046896_148046991 | -0.86 | 3.1e-04 | Click! |
Foxa1 | mm10_v2_chr12_-_57546121_57546141 | -0.70 | 1.1e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_104766334 | 9.12 |
ENSMUST00000065072.6
|
C8b
|
complement component 8, beta polypeptide |
chr4_+_104766308 | 7.73 |
ENSMUST00000031663.3
|
C8b
|
complement component 8, beta polypeptide |
chr3_-_113258837 | 6.44 |
ENSMUST00000098673.3
|
Amy2a5
|
amylase 2a5 |
chr3_-_113532288 | 5.54 |
ENSMUST00000132353.1
|
Amy2a1
|
amylase 2a1 |
chr2_-_62483637 | 4.70 |
ENSMUST00000136686.1
ENSMUST00000102733.3 |
Gcg
|
glucagon |
chrX_-_108664891 | 4.36 |
ENSMUST00000178160.1
|
Gm379
|
predicted gene 379 |
chr6_+_90619241 | 4.27 |
ENSMUST00000032177.8
|
Slc41a3
|
solute carrier family 41, member 3 |
chr5_-_108795352 | 4.08 |
ENSMUST00000004943.1
|
Tmed11
|
transmembrane emp24 protein transport domain containing |
chr6_+_30541582 | 3.73 |
ENSMUST00000096066.4
|
Cpa2
|
carboxypeptidase A2, pancreatic |
chrX_+_101376359 | 3.54 |
ENSMUST00000119080.1
|
Gjb1
|
gap junction protein, beta 1 |
chr2_+_164403194 | 3.53 |
ENSMUST00000017151.1
|
Rbpjl
|
recombination signal binding protein for immunoglobulin kappa J region-like |
chr14_+_103513328 | 3.42 |
ENSMUST00000095576.3
|
Scel
|
sciellin |
chr17_-_31144271 | 3.36 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr10_+_115817247 | 3.34 |
ENSMUST00000035563.7
ENSMUST00000080630.3 ENSMUST00000179196.1 |
Tspan8
|
tetraspanin 8 |
chr16_-_22439719 | 3.30 |
ENSMUST00000079601.6
|
Etv5
|
ets variant gene 5 |
chr6_-_136922169 | 2.97 |
ENSMUST00000032343.6
|
Erp27
|
endoplasmic reticulum protein 27 |
chr7_+_131032061 | 2.96 |
ENSMUST00000084509.3
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr17_+_70522083 | 2.89 |
ENSMUST00000148486.1
ENSMUST00000133717.1 |
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr3_-_20275659 | 2.88 |
ENSMUST00000011607.5
|
Cpb1
|
carboxypeptidase B1 (tissue) |
chrX_+_164140447 | 2.86 |
ENSMUST00000073973.4
|
Ace2
|
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2 |
chr11_+_96929260 | 2.82 |
ENSMUST00000054311.5
ENSMUST00000107636.3 |
Prr15l
|
proline rich 15-like |
chr5_-_86906937 | 2.72 |
ENSMUST00000031181.9
ENSMUST00000113333.1 |
Ugt2b34
|
UDP glucuronosyltransferase 2 family, polypeptide B34 |
chr11_+_96929367 | 2.65 |
ENSMUST00000062172.5
|
Prr15l
|
proline rich 15-like |
chr12_-_103657159 | 2.61 |
ENSMUST00000044159.6
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr9_+_74848437 | 2.61 |
ENSMUST00000161862.1
ENSMUST00000162089.1 ENSMUST00000160017.1 ENSMUST00000160950.1 |
Gm16551
Gm20649
|
predicted gene 16551 predicted gene 20649 |
chr11_-_99986593 | 2.38 |
ENSMUST00000105050.2
|
Krtap16-1
|
keratin associated protein 16-1 |
chr11_-_100146120 | 2.35 |
ENSMUST00000007317.7
|
Krt19
|
keratin 19 |
chr11_+_32000452 | 2.17 |
ENSMUST00000020537.2
ENSMUST00000109409.1 |
Nsg2
|
neuron specific gene family member 2 |
chr13_-_95478655 | 2.11 |
ENSMUST00000022186.3
|
S100z
|
S100 calcium binding protein, zeta |
chr4_-_57916283 | 2.08 |
ENSMUST00000063816.5
|
D630039A03Rik
|
RIKEN cDNA D630039A03 gene |
chr18_-_60648290 | 2.04 |
ENSMUST00000143275.2
|
Synpo
|
synaptopodin |
chr10_-_93311073 | 2.02 |
ENSMUST00000008542.5
|
Elk3
|
ELK3, member of ETS oncogene family |
chr10_-_93310963 | 2.02 |
ENSMUST00000151153.1
|
Elk3
|
ELK3, member of ETS oncogene family |
chr6_-_87388878 | 2.01 |
ENSMUST00000032127.4
|
Gkn3
|
gastrokine 3 |
chr1_-_74885322 | 1.91 |
ENSMUST00000159232.1
ENSMUST00000068631.3 |
Fev
|
FEV (ETS oncogene family) |
chr5_+_102481374 | 1.85 |
ENSMUST00000094559.2
ENSMUST00000073302.5 |
Arhgap24
|
Rho GTPase activating protein 24 |
chr9_+_37539255 | 1.82 |
ENSMUST00000002008.5
|
Vsig2
|
V-set and immunoglobulin domain containing 2 |
chr9_-_107668967 | 1.78 |
ENSMUST00000177567.1
|
Slc38a3
|
solute carrier family 38, member 3 |
chr14_+_41131777 | 1.73 |
ENSMUST00000022314.3
ENSMUST00000170719.1 |
Sftpa1
|
surfactant associated protein A1 |
chr11_+_94565039 | 1.72 |
ENSMUST00000040418.8
|
Chad
|
chondroadherin |
chr16_+_17331371 | 1.70 |
ENSMUST00000023450.6
ENSMUST00000161034.1 |
Serpind1
|
serine (or cysteine) peptidase inhibitor, clade D, member 1 |
chr3_-_106167564 | 1.65 |
ENSMUST00000063062.8
|
Chi3l3
|
chitinase 3-like 3 |
chr17_+_70522149 | 1.63 |
ENSMUST00000140728.1
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr5_+_102481546 | 1.60 |
ENSMUST00000112854.1
|
Arhgap24
|
Rho GTPase activating protein 24 |
chr1_+_156838915 | 1.53 |
ENSMUST00000111720.1
|
Angptl1
|
angiopoietin-like 1 |
chr11_+_87699897 | 1.53 |
ENSMUST00000040089.4
|
Rnf43
|
ring finger protein 43 |
chr5_-_123865491 | 1.52 |
ENSMUST00000057145.5
|
Niacr1
|
niacin receptor 1 |
chr14_-_110755100 | 1.50 |
ENSMUST00000078386.2
|
Slitrk6
|
SLIT and NTRK-like family, member 6 |
chr11_-_68386821 | 1.47 |
ENSMUST00000021284.3
|
Ntn1
|
netrin 1 |
chr14_+_73237891 | 1.44 |
ENSMUST00000044405.6
|
Lpar6
|
lysophosphatidic acid receptor 6 |
chr6_-_41446062 | 1.42 |
ENSMUST00000095999.5
|
Gm10334
|
predicted gene 10334 |
chr8_-_45294854 | 1.40 |
ENSMUST00000116473.2
|
Klkb1
|
kallikrein B, plasma 1 |
chr10_-_41611319 | 1.35 |
ENSMUST00000179614.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr17_+_68837062 | 1.34 |
ENSMUST00000178545.1
|
Tmem200c
|
transmembrane protein 200C |
chr16_+_33518278 | 1.33 |
ENSMUST00000122427.1
ENSMUST00000059056.8 |
Slc12a8
|
solute carrier family 12 (potassium/chloride transporters), member 8 |
chr2_-_172940299 | 1.33 |
ENSMUST00000009143.7
|
Bmp7
|
bone morphogenetic protein 7 |
chr4_+_102570065 | 1.32 |
ENSMUST00000097950.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr11_+_110399115 | 1.30 |
ENSMUST00000020949.5
ENSMUST00000100260.1 |
Map2k6
|
mitogen-activated protein kinase kinase 6 |
chr4_-_103026709 | 1.26 |
ENSMUST00000084382.5
ENSMUST00000106869.2 |
Insl5
|
insulin-like 5 |
chr16_+_33518528 | 1.22 |
ENSMUST00000119173.1
|
Slc12a8
|
solute carrier family 12 (potassium/chloride transporters), member 8 |
chr2_-_163645125 | 1.20 |
ENSMUST00000017851.3
|
Serinc3
|
serine incorporator 3 |
chr2_-_72813665 | 1.19 |
ENSMUST00000136807.1
ENSMUST00000148327.1 |
6430710C18Rik
|
RIKEN cDNA 6430710C18 gene |
chr6_+_5390387 | 1.18 |
ENSMUST00000183358.1
|
Asb4
|
ankyrin repeat and SOCS box-containing 4 |
chr19_-_58455398 | 1.16 |
ENSMUST00000026076.7
|
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr3_+_69222412 | 1.15 |
ENSMUST00000183126.1
|
Arl14
|
ADP-ribosylation factor-like 14 |
chr16_+_22892035 | 1.14 |
ENSMUST00000023583.5
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr3_-_113291449 | 1.10 |
ENSMUST00000179568.1
|
Amy2a4
|
amylase 2a4 |
chr3_-_113324052 | 1.10 |
ENSMUST00000179314.1
|
Amy2a3
|
amylase 2a3 |
chr3_-_101836223 | 1.07 |
ENSMUST00000061831.4
|
Mab21l3
|
mab-21-like 3 (C. elegans) |
chr3_-_145032765 | 1.06 |
ENSMUST00000029919.5
|
Clca3
|
chloride channel calcium activated 3 |
chr14_-_93888732 | 1.06 |
ENSMUST00000068992.2
|
Pcdh9
|
protocadherin 9 |
chr15_-_66560997 | 1.05 |
ENSMUST00000048372.5
|
Tmem71
|
transmembrane protein 71 |
chr6_+_97991776 | 1.04 |
ENSMUST00000043628.6
|
Mitf
|
microphthalmia-associated transcription factor |
chr14_-_41185188 | 1.04 |
ENSMUST00000077136.3
|
Sftpd
|
surfactant associated protein D |
chr2_+_26973416 | 1.03 |
ENSMUST00000014996.7
ENSMUST00000102891.3 |
Adamts13
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 13 |
chr1_-_39720989 | 1.03 |
ENSMUST00000151913.1
|
Rfx8
|
regulatory factor X 8 |
chr1_+_179546303 | 1.03 |
ENSMUST00000040706.8
|
Cnst
|
consortin, connexin sorting protein |
chr12_+_119443410 | 1.01 |
ENSMUST00000048880.6
|
Macc1
|
metastasis associated in colon cancer 1 |
chr5_+_75152274 | 0.99 |
ENSMUST00000000476.8
|
Pdgfra
|
platelet derived growth factor receptor, alpha polypeptide |
chr16_-_22657182 | 0.99 |
ENSMUST00000023578.7
|
Dgkg
|
diacylglycerol kinase, gamma |
chr17_-_56121946 | 0.98 |
ENSMUST00000041357.7
|
Lrg1
|
leucine-rich alpha-2-glycoprotein 1 |
chr10_-_128180265 | 0.97 |
ENSMUST00000099139.1
|
Rbms2
|
RNA binding motif, single stranded interacting protein 2 |
chr15_+_10223974 | 0.95 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
Prlr
|
prolactin receptor |
chr3_+_19957240 | 0.95 |
ENSMUST00000108325.2
|
Cp
|
ceruloplasmin |
chr8_+_127064022 | 0.94 |
ENSMUST00000160272.1
ENSMUST00000079777.5 ENSMUST00000162907.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr10_+_87861309 | 0.94 |
ENSMUST00000122100.1
|
Igf1
|
insulin-like growth factor 1 |
chr6_+_34863130 | 0.94 |
ENSMUST00000074949.3
|
Tmem140
|
transmembrane protein 140 |
chr1_-_87573825 | 0.93 |
ENSMUST00000068681.5
|
Ngef
|
neuronal guanine nucleotide exchange factor |
chr14_+_55853997 | 0.90 |
ENSMUST00000100529.3
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr3_+_135825648 | 0.89 |
ENSMUST00000180196.1
|
Slc39a8
|
solute carrier family 39 (metal ion transporter), member 8 |
chr7_-_29168647 | 0.88 |
ENSMUST00000048923.6
|
Spred3
|
sprouty-related, EVH1 domain containing 3 |
chr4_-_63154130 | 0.88 |
ENSMUST00000030041.4
|
Ambp
|
alpha 1 microglobulin/bikunin |
chr4_+_150853919 | 0.88 |
ENSMUST00000073600.2
|
Errfi1
|
ERBB receptor feedback inhibitor 1 |
chr7_-_100656953 | 0.87 |
ENSMUST00000107046.1
ENSMUST00000107045.1 ENSMUST00000139708.1 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr8_+_107119110 | 0.85 |
ENSMUST00000046116.1
|
C630050I24Rik
|
RIKEN cDNA C630050I24 gene |
chr9_+_46228580 | 0.84 |
ENSMUST00000034588.8
|
Apoa1
|
apolipoprotein A-I |
chr6_+_139843648 | 0.83 |
ENSMUST00000087657.6
|
Pik3c2g
|
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide |
chr8_-_65129317 | 0.81 |
ENSMUST00000098713.3
|
BC030870
|
cDNA sequence BC030870 |
chr14_-_30943275 | 0.81 |
ENSMUST00000006704.8
ENSMUST00000163118.1 |
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1 |
chr2_-_70825726 | 0.81 |
ENSMUST00000038584.8
|
Tlk1
|
tousled-like kinase 1 |
chr13_+_111867931 | 0.81 |
ENSMUST00000128198.1
|
Gm15326
|
predicted gene 15326 |
chr16_-_22161450 | 0.80 |
ENSMUST00000115379.1
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr2_+_125136692 | 0.78 |
ENSMUST00000099452.2
|
Ctxn2
|
cortexin 2 |
chr14_+_55854115 | 0.77 |
ENSMUST00000168479.1
|
Nynrin
|
NYN domain and retroviral integrase containing |
chr2_+_137663424 | 0.75 |
ENSMUST00000134833.1
|
Gm14064
|
predicted gene 14064 |
chr18_+_69925542 | 0.75 |
ENSMUST00000080050.5
|
Ccdc68
|
coiled-coil domain containing 68 |
chr4_-_55532453 | 0.75 |
ENSMUST00000132746.1
ENSMUST00000107619.2 |
Klf4
|
Kruppel-like factor 4 (gut) |
chr2_-_60722636 | 0.74 |
ENSMUST00000028348.2
ENSMUST00000112517.1 |
Itgb6
|
integrin beta 6 |
chr2_+_30595037 | 0.74 |
ENSMUST00000102853.3
|
Cstad
|
CSA-conditional, T cell activation-dependent protein |
chr13_+_5861489 | 0.71 |
ENSMUST00000000080.6
|
Klf6
|
Kruppel-like factor 6 |
chr2_+_24345305 | 0.71 |
ENSMUST00000114482.1
|
Il1rn
|
interleukin 1 receptor antagonist |
chr11_+_114851142 | 0.71 |
ENSMUST00000133245.1
ENSMUST00000122967.2 |
Gprc5c
|
G protein-coupled receptor, family C, group 5, member C |
chr18_+_69925466 | 0.70 |
ENSMUST00000043929.4
|
Ccdc68
|
coiled-coil domain containing 68 |
chr1_+_75142775 | 0.70 |
ENSMUST00000097694.4
|
Fam134a
|
family with sequence similarity 134, member A |
chr4_+_102254993 | 0.70 |
ENSMUST00000106908.2
|
Pde4b
|
phosphodiesterase 4B, cAMP specific |
chr6_-_52183828 | 0.69 |
ENSMUST00000134831.1
|
Hoxa3
|
homeobox A3 |
chr11_+_78499087 | 0.69 |
ENSMUST00000017488.4
|
Vtn
|
vitronectin |
chr7_+_113765998 | 0.67 |
ENSMUST00000046687.9
|
Spon1
|
spondin 1, (f-spondin) extracellular matrix protein |
chr14_+_61607455 | 0.66 |
ENSMUST00000051184.8
|
Kcnrg
|
potassium channel regulator |
chr19_-_58455161 | 0.66 |
ENSMUST00000135730.1
ENSMUST00000152507.1 |
Gfra1
|
glial cell line derived neurotrophic factor family receptor alpha 1 |
chr5_+_90561102 | 0.65 |
ENSMUST00000094615.4
|
5830473C10Rik
|
RIKEN cDNA 5830473C10 gene |
chr2_+_58755177 | 0.65 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr8_-_121083085 | 0.64 |
ENSMUST00000182264.1
|
Fendrr
|
Foxf1 adjacent non-coding developmental regulatory RNA |
chr4_-_58499398 | 0.63 |
ENSMUST00000107570.1
|
Lpar1
|
lysophosphatidic acid receptor 1 |
chr2_+_158306493 | 0.63 |
ENSMUST00000016168.2
ENSMUST00000109491.1 |
Lbp
|
lipopolysaccharide binding protein |
chr13_-_12464925 | 0.62 |
ENSMUST00000124888.1
|
Lgals8
|
lectin, galactose binding, soluble 8 |
chr3_+_27154020 | 0.61 |
ENSMUST00000181124.1
|
1700125G22Rik
|
RIKEN cDNA 1700125G22 gene |
chr19_+_56461629 | 0.60 |
ENSMUST00000178590.1
ENSMUST00000039666.6 |
Plekhs1
|
pleckstrin homology domain containing, family S member 1 |
chr7_+_43351378 | 0.60 |
ENSMUST00000012798.7
ENSMUST00000122423.1 ENSMUST00000121494.1 |
Siglec5
|
sialic acid binding Ig-like lectin 5 |
chr15_+_4727175 | 0.59 |
ENSMUST00000162585.1
|
C6
|
complement component 6 |
chr7_+_19359740 | 0.59 |
ENSMUST00000140836.1
|
Ppp1r13l
|
protein phosphatase 1, regulatory (inhibitor) subunit 13 like |
chr2_-_51972990 | 0.59 |
ENSMUST00000145481.1
ENSMUST00000112705.2 |
Nmi
|
N-myc (and STAT) interactor |
chr18_-_60501983 | 0.58 |
ENSMUST00000042710.6
|
Smim3
|
small integral membrane protein 3 |
chr3_+_19957037 | 0.58 |
ENSMUST00000091309.5
ENSMUST00000108329.1 ENSMUST00000003714.6 |
Cp
|
ceruloplasmin |
chr11_-_99438143 | 0.58 |
ENSMUST00000017743.2
|
Krt20
|
keratin 20 |
chr18_+_37742088 | 0.58 |
ENSMUST00000003599.6
|
Pcdhga9
|
protocadherin gamma subfamily A, 9 |
chr11_-_99993992 | 0.58 |
ENSMUST00000105049.1
|
Krtap17-1
|
keratin associated protein 17-1 |
chr2_-_51973219 | 0.58 |
ENSMUST00000028314.2
|
Nmi
|
N-myc (and STAT) interactor |
chr1_-_136960427 | 0.57 |
ENSMUST00000027649.7
|
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr11_-_101226414 | 0.57 |
ENSMUST00000100417.2
ENSMUST00000107285.1 ENSMUST00000107284.1 |
Ezh1
|
enhancer of zeste homolog 1 (Drosophila) |
chr2_-_154613425 | 0.56 |
ENSMUST00000181369.1
|
4930519P11Rik
|
RIKEN cDNA 4930519P11 gene |
chr13_+_49582745 | 0.56 |
ENSMUST00000065494.7
|
Omd
|
osteomodulin |
chr6_+_134830216 | 0.56 |
ENSMUST00000111937.1
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr10_+_99263224 | 0.56 |
ENSMUST00000020118.4
|
Dusp6
|
dual specificity phosphatase 6 |
chr18_-_84086379 | 0.55 |
ENSMUST00000060303.8
|
Tshz1
|
teashirt zinc finger family member 1 |
chr18_+_51117754 | 0.55 |
ENSMUST00000116639.2
|
Prr16
|
proline rich 16 |
chr2_+_58754910 | 0.55 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr5_-_103211251 | 0.54 |
ENSMUST00000060871.5
ENSMUST00000112846.1 ENSMUST00000170792.1 ENSMUST00000112847.2 |
Mapk10
|
mitogen-activated protein kinase 10 |
chr1_-_156034800 | 0.54 |
ENSMUST00000169241.1
|
Tor1aip1
|
torsin A interacting protein 1 |
chr1_-_166409773 | 0.54 |
ENSMUST00000135673.1
ENSMUST00000079972.6 ENSMUST00000169324.1 ENSMUST00000111411.2 ENSMUST00000128861.1 |
Pogk
|
pogo transposable element with KRAB domain |
chrX_+_106920618 | 0.53 |
ENSMUST00000060576.7
|
Lpar4
|
lysophosphatidic acid receptor 4 |
chrX_+_136707976 | 0.52 |
ENSMUST00000055104.5
|
Tceal1
|
transcription elongation factor A (SII)-like 1 |
chr17_+_46161021 | 0.52 |
ENSMUST00000024748.7
ENSMUST00000172170.1 |
Gtpbp2
|
GTP binding protein 2 |
chr5_+_16553488 | 0.51 |
ENSMUST00000030683.3
|
Hgf
|
hepatocyte growth factor |
chr3_-_46447939 | 0.51 |
ENSMUST00000166505.1
|
Pabpc4l
|
poly(A) binding protein, cytoplasmic 4-like |
chr19_+_55741810 | 0.51 |
ENSMUST00000111657.3
ENSMUST00000061496.9 ENSMUST00000041717.7 ENSMUST00000111662.4 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr12_-_31950535 | 0.50 |
ENSMUST00000172314.2
|
Hbp1
|
high mobility group box transcription factor 1 |
chrX_-_155623325 | 0.50 |
ENSMUST00000038665.5
|
Ptchd1
|
patched domain containing 1 |
chr3_+_137867675 | 0.50 |
ENSMUST00000090178.5
|
Dnajb14
|
DnaJ (Hsp40) homolog, subfamily B, member 14 |
chr5_+_107437908 | 0.50 |
ENSMUST00000094541.2
|
Btbd8
|
BTB (POZ) domain containing 8 |
chr9_+_107975529 | 0.48 |
ENSMUST00000035216.4
|
Uba7
|
ubiquitin-like modifier activating enzyme 7 |
chr12_+_77238093 | 0.48 |
ENSMUST00000177595.1
ENSMUST00000171770.2 |
Fut8
|
fucosyltransferase 8 |
chr19_-_37207293 | 0.47 |
ENSMUST00000132580.1
ENSMUST00000079754.4 ENSMUST00000136286.1 ENSMUST00000126188.1 ENSMUST00000126781.1 |
Cpeb3
|
cytoplasmic polyadenylation element binding protein 3 |
chr7_-_44849075 | 0.47 |
ENSMUST00000047085.8
|
Tbc1d17
|
TBC1 domain family, member 17 |
chr1_-_126830632 | 0.47 |
ENSMUST00000112583.1
ENSMUST00000094609.3 |
Nckap5
|
NCK-associated protein 5 |
chr19_+_55741884 | 0.47 |
ENSMUST00000111658.3
ENSMUST00000111654.1 |
Tcf7l2
|
transcription factor 7 like 2, T cell specific, HMG box |
chr3_-_52104891 | 0.47 |
ENSMUST00000121440.1
|
Maml3
|
mastermind like 3 (Drosophila) |
chr16_-_22657165 | 0.47 |
ENSMUST00000089925.3
|
Dgkg
|
diacylglycerol kinase, gamma |
chr5_-_35679416 | 0.47 |
ENSMUST00000114233.2
|
Htra3
|
HtrA serine peptidase 3 |
chr3_+_96219858 | 0.46 |
ENSMUST00000073115.4
|
Hist2h2ab
|
histone cluster 2, H2ab |
chr10_+_96616998 | 0.45 |
ENSMUST00000038377.7
|
Btg1
|
B cell translocation gene 1, anti-proliferative |
chr3_+_19957088 | 0.45 |
ENSMUST00000108328.1
|
Cp
|
ceruloplasmin |
chr17_+_46161111 | 0.44 |
ENSMUST00000166563.1
|
Gtpbp2
|
GTP binding protein 2 |
chrX_+_163911401 | 0.44 |
ENSMUST00000140845.1
|
Ap1s2
|
adaptor-related protein complex 1, sigma 2 subunit |
chr15_-_5108469 | 0.44 |
ENSMUST00000141020.1
|
Card6
|
caspase recruitment domain family, member 6 |
chr13_+_113342548 | 0.44 |
ENSMUST00000078163.7
|
BC067074
|
cDNA sequence BC067074 |
chr6_+_142298419 | 0.43 |
ENSMUST00000041993.2
|
Iapp
|
islet amyloid polypeptide |
chr10_-_33624587 | 0.42 |
ENSMUST00000160299.1
ENSMUST00000019920.6 |
Clvs2
|
clavesin 2 |
chrX_+_159708593 | 0.42 |
ENSMUST00000080394.6
|
Sh3kbp1
|
SH3-domain kinase binding protein 1 |
chr18_+_36952621 | 0.41 |
ENSMUST00000115661.2
|
Pcdha2
|
protocadherin alpha 2 |
chr1_+_43445736 | 0.41 |
ENSMUST00000086421.5
ENSMUST00000114744.1 |
Nck2
|
non-catalytic region of tyrosine kinase adaptor protein 2 |
chr11_+_85832551 | 0.40 |
ENSMUST00000000095.6
|
Tbx2
|
T-box 2 |
chr8_-_45262012 | 0.40 |
ENSMUST00000034064.3
|
F11
|
coagulation factor XI |
chr13_-_74807913 | 0.40 |
ENSMUST00000065629.4
|
Cast
|
calpastatin |
chr6_-_137571007 | 0.40 |
ENSMUST00000100841.2
|
Eps8
|
epidermal growth factor receptor pathway substrate 8 |
chr2_+_24336846 | 0.40 |
ENSMUST00000114487.2
|
Il1rn
|
interleukin 1 receptor antagonist |
chr6_+_134830145 | 0.39 |
ENSMUST00000046303.5
|
Crebl2
|
cAMP responsive element binding protein-like 2 |
chr16_-_38294774 | 0.39 |
ENSMUST00000023504.4
|
Nr1i2
|
nuclear receptor subfamily 1, group I, member 2 |
chr16_-_29378667 | 0.39 |
ENSMUST00000143373.1
ENSMUST00000075806.4 |
Atp13a5
|
ATPase type 13A5 |
chr1_+_51289106 | 0.39 |
ENSMUST00000051572.6
|
Sdpr
|
serum deprivation response |
chr18_+_21072329 | 0.38 |
ENSMUST00000082235.4
|
Mep1b
|
meprin 1 beta |
chr4_+_43669610 | 0.38 |
ENSMUST00000107866.1
|
Tmem8b
|
transmembrane protein 8B |
chr18_-_3281036 | 0.38 |
ENSMUST00000049942.6
ENSMUST00000139537.1 ENSMUST00000124747.1 |
Crem
|
cAMP responsive element modulator |
chr9_+_86743641 | 0.37 |
ENSMUST00000179574.1
|
Prss35
|
protease, serine, 35 |
chr9_+_43744399 | 0.37 |
ENSMUST00000034510.7
|
Pvrl1
|
poliovirus receptor-related 1 |
chr5_-_122989086 | 0.37 |
ENSMUST00000046073.9
|
Kdm2b
|
lysine (K)-specific demethylase 2B |
chr6_+_92940572 | 0.36 |
ENSMUST00000181145.1
ENSMUST00000181840.1 |
9530026P05Rik
|
RIKEN cDNA 9530026P05 gene |
chr1_-_157256682 | 0.36 |
ENSMUST00000134543.1
|
Rasal2
|
RAS protein activator like 2 |
chr2_-_170427828 | 0.36 |
ENSMUST00000013667.2
ENSMUST00000109152.2 ENSMUST00000068137.4 |
Bcas1
|
breast carcinoma amplified sequence 1 |
chr15_+_5185700 | 0.36 |
ENSMUST00000081640.5
|
Ttc33
|
tetratricopeptide repeat domain 33 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 16.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 2.9 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.7 | 4.7 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.6 | 1.8 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.6 | 3.4 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.6 | 3.3 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.5 | 1.5 | GO:0060005 | vestibular reflex(GO:0060005) |
0.4 | 1.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 3.5 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.4 | 2.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.4 | 2.0 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.4 | 1.2 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.3 | 4.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 1.0 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 1.0 | GO:0072277 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.3 | 3.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.3 | 2.8 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 1.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.3 | 1.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.3 | 0.8 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 1.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 1.2 | GO:0009597 | detection of virus(GO:0009597) |
0.2 | 1.2 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 1.9 | GO:0051611 | regulation of serotonin uptake(GO:0051611) |
0.2 | 0.8 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.2 | 1.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.2 | 0.6 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.2 | 1.7 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 2.0 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.2 | 0.9 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.6 | GO:1990401 | embryonic lung development(GO:1990401) |
0.2 | 1.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.2 | 0.5 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.2 | 0.6 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.9 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.2 | 3.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 1.3 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.4 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 1.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.4 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.1 | 0.5 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.7 | GO:0021615 | specification of organ position(GO:0010159) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 1.3 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 1.3 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.1 | 0.4 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 1.2 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.7 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 0.3 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.1 | 0.3 | GO:0071895 | negative regulation of interleukin-13 production(GO:0032696) odontoblast differentiation(GO:0071895) |
0.1 | 0.6 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 0.4 | GO:1903898 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.1 | 2.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.5 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.1 | 0.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 0.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.4 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.1 | 0.3 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.1 | 0.9 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 1.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 2.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.1 | 2.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) xenobiotic transport(GO:0042908) |
0.1 | 0.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 3.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.1 | 0.7 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 2.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.5 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.2 | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.1 | 2.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 1.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 2.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.7 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.2 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.0 | 0.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.7 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.0 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0090154 | apoptotic process involved in heart morphogenesis(GO:0003278) positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 3.0 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.0 | 0.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
0.0 | 0.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.6 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.2 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 0.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.5 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.2 | GO:0031179 | peptide modification(GO:0031179) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.1 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 1.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.0 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.0 | 2.1 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.0 | 0.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.4 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 2.4 | GO:0042060 | wound healing(GO:0042060) |
0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.0 | 0.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.0 | 2.5 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 0.6 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 0.0 | GO:1904868 | pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.0 | 0.9 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 17.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 3.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 2.3 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 2.0 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 0.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.2 | 0.6 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.2 | 3.7 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 1.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 1.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 0.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 2.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 2.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 2.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.2 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 2.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.3 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.2 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 1.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.6 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 1.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 16.2 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 8.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.0 | 4.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 1.8 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.4 | 2.9 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.4 | 1.2 | GO:0045353 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 receptor antagonist activity(GO:0005152) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
0.4 | 2.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 3.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 2.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 2.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 6.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 2.0 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 1.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 0.7 | GO:0005118 | sevenless binding(GO:0005118) |
0.2 | 3.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 1.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 1.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.2 | 0.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 1.1 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.1 | 0.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.1 | 1.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 2.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.6 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 1.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.4 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 2.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 3.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 1.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 2.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.2 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) leukemia inhibitory factor receptor activity(GO:0004923) interleukin-6 binding(GO:0019981) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.2 | GO:0016842 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) amidine-lyase activity(GO:0016842) |
0.0 | 1.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 4.7 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 2.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.0 | 5.2 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.0 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.5 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.5 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.3 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.0 | 1.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 1.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.2 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.0 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 2.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.3 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 8.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 3.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 4.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 0.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 2.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 5.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 2.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 4.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 1.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 16.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 5.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 1.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 3.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 1.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 2.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 1.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.0 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.5 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 1.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 1.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 1.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.0 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.0 | 0.5 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 2.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |